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Summary
Objective: The Osteoarthritis Initiative (OAI) is aimed at validating (imaging) biomarkers for monitoring progression of knee OA. Here we an-
alyze regional femorotibial (FT) cartilage thickness changes over 1 year using 3 Tesla MRI. Speciﬁcally, we tested whether changes in central
subregions exceed those in the total cartilage plates.
Methods: The right knees of a subsample of the OAI progression subcohort (n¼ 156, age 60.9 9.9 years) were studied. Fifty-four partici-
pants had deﬁnite radiographic osteoarthritis (OA) (KLG 2 or 3) and a BMI> 30. Mean and minimal cartilage thickness were determined in
subregions of the medial/lateral tibia (MT/LT), and of the medial/lateral weight-bearing femoral condyle (cMF/cLF), after paired (baseline, fol-
low up) segmentation of coronal FLASHwe images with blinding to the order of acquisition.
Results: The central aspect of cMF displayed a 5.8%/2.8% change in mean thickness in the group of 54/156 participants, respectively, with
a standardized response mean (SRM) of 0.47/0.31, whereas cartilage loss in the total cMF was 4.1%/1.9% (SRM 0.49/0.30). In the
central MT, the rate of change was 1.6%/0.9% and the SRM 0.29/0.20, whereas for the entire MT the rate was 1.0%/0.5% and
the SRM 0.21/0.12. Minimal thickness displayed greater rates of change, but lower SRMs than mean thickness.
Conclusions: This study shows that the rate of cartilage loss is greater in central subregions than in entire FT cartilage plates. The sensitivity to
change in central subregions was higher than for the total cartilage plate in the MT and was similar to the total plate in the medial
weight-bearing femur.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Magnetic resonance imaging (MRI) provides the opportunity
to measure articular cartilage loss and other structural
changes in knee osteoarthritis (OA) directly and three-di-
mensionally, whereas radiography is limited to the analysis
of projections of the bone contours (i.e., joint space narrow-
ing). MRI not only circumvents the challenges in appropriate
positioning of the knee vs a two-dimensional ﬁlm, but also
permits one to acquire more comprehensive information
on cartilage loss by providing speciﬁc information on each
of the contacting cartilage plates in the femorotibial (FT)
joint. Moreover, cartilage loss can be measured in subre-
gions (i.e., central, internal, external) of FT cartilage pla-
tes1e3, so one can gain additional insight into the spatial*Address correspondence and reprint requests to: Prof. Felix
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291distribution of tissue loss throughout the cartilage plates in
OA. Assuming that cartilage is not lost homogeneously
throughout the plates, this approach may be used to identify
subregions with a higher rate and sensitivity to change,
which may, in turn, permit reductions in sample size in clin-
ical studies for demonstrating, for instance, structure modi-
fying effects of pharmaceutical compounds on disease
progression.
We have recently presented a technique by which tibial
cartilage can be reliably divided into central, internal, external,
anterior, andposterior subregions,and theweight-bearingpart
of the femoral condyles into central, internal and external sub-
regions, based on segmentation of the total subchondral bone
area3 (tAB). In a recent study by another group2, the highest
rates of change (% cartilage loss) were found in the central
regions of the FT cartilages at 1.5 Tesla (T). However, these
subregions appeared to have no advantage in terms of sensi-
tivity for detecting change due to a proportional increase in the
variability of change.
Division of cartilage plates into subregions has the addi-
tional advantage that the minimal cartilage thickness can
292 W. Wirth et al.: Regional cartilage loss in OAI progression subcohortbe measured in central areas, whereas for total cartilage
plates the minimal cartilage thickness always drops off to-
wards zero towards the joint margins. Analogous to radiog-
raphy, where minimal joint space width is considered a gold
standard for measuring disease progression4, regionaliza-
tion has the advantage that the minimal cartilage thickness
can be monitored three-dimensionally in the central joint
areas. In a diseased joint, the minimal cartilage thickness
may potentially be more sensitive to change than the
mean thickness, because in central areas it is likely located
at the site of a lesion, where cartilage loss may occur faster
than in other parts of the joint surface.
Here we investigated whether subregional analysis of FT
cartilage with 3 T MRI, testing central subregions of different
sizes3 as well as mean and minimal cartilage thickness3,
speciﬁc areas/parameters can be identiﬁed that provide
a higher sensitivity to cartilage loss over time than the anal-
ysis of entire FT cartilage plates5. Speciﬁcally, we tested the
hypothesis that changes in central subregions of the FT car-
tilages exceed those in total cartilage plates.ecMF
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Fig. 1. Image showing the standard (default) FT subregions, with
cMT covering 20% of the tibial subchondral bone area and ccMF
covering 33% of the femoral subchondral bone area, respectively:
(A) Posterior view of FT subchondral bone areas (tibia at the bot-
tom, weight-bearing femur at the top), with subregions displayed
by different gray values. (B) Superior view of the tibial subchondral
bone area, with subregions labeled. (C) Inferior view of the femoral
subchondral bone area, with subregions labeled cMF¼ central
(weight-bearing) medial femoral condyle, ccMF ¼ central cMF,
ecMF ¼ external cMF, icMF ¼ internal cMF, MT ¼medial tibia,
cMT ¼ central MT, eMT ¼ external MT, iMT ¼ internal MT,
aMT¼ anterior MT, pMT¼ posterior MT.Methods
An age and gender stratiﬁed subsample of the Osteoarthritis Initiative
(OAI) progression subcohort was studied (OAI public-use datasets 0.1.1,
0.B.1 and 1.B.1)5, for which baseline and 1 year follow up MRI data were
available. The subsample included 79 women with a mean (standard devi-
ation, SD) age of 60.3 9.5 years (BMI¼ 30.3 5.5) and 77 men, aged
62.0 10.2 years (BMI¼ 30.1 3.7). Participants were aged 45e79 years;
79 participants displayed a BMI of >30. The participants all had frequent
knee symptoms (pain, aching or stiffness on most days of a month in past
year) and radiographic OA (deﬁnite osteophytes in the postero-anterior
[pa] ﬁxed ﬂexion radiographs6,7) in at least one knee in the initial readings
of the baseline radiographs at the imaging sites. The baseline radiographs
were acquired at the same time as the baseline MRIs. In a separate assess-
ment, the baseline radiographs were then read independently by two readers
(one musculoskeletal radiologist and one rheumatologist) at Boston Univer-
sity for KellgreneLawrence (KeL) grade. When there was a discrepancy in
OA status by KeL grade (0e1 vs 2), readings were adjudicated by consen-
sus with a third reader present. The results of these adjudicated reading
were used in the present analysis. No data on knee alignment was available
for this cohort.
The MRI sequence used to quantify cartilage morphology (see below) was
only available in the right knees, whereas some participants displayed symp-
tomatic and radiographic OA in their left knee. Further the adjudicated central
radiographic readings differed slightly from the initial screening readings at the
sites. Therefore, not all knees analyzed displayed radiographic knee OA. Of
the 156 knees analyzed, 17 showed KeL grade¼ 0, 29 grade 1, 56 grade 2,
47 grade 3 and 7 grade 4. BMI has been identiﬁed as a risk factor for OA pro-
gression2,8,9 and in a previous analysis of total cartilage plate changes in this
cohort we found a trend for subjects with KeL grade 2 and 3 and high BMI to
display greater cartilage thinning over 1 year than in those with low BMI and
other KeL grades5. Also, clinical trials often include subjects with high BMI
and deﬁnite radiographic OA, but not with end stage radiographic OA (KeL
grade¼ 4), because there is little cartilage left to loose in the latter. For this rea-
son, we additionally analyzed regional cartilage change in a ‘‘high risk’’ subco-
hort with KeL grade 2 or 3 radiographic OA and a BMI> 30 (n¼ 54).
Double oblique coronal 3D fast low angle shot (FLASH) MR images with
water excitation (we), a slice thickness of 1.5 mm and an in plane resolution
of 0.31 mm 0.31 mm of the right knees were obtained at baseline and at
year one follow up using 3 T MR scanners (Siemens Magnetom Trio, Erlan-
gen, Germany) and a quadrature transmit-receive knee coils (USA Instru-
ments, Aurora, OH). For further technical details on this imaging please
see previous publications5,10e12. The reason for analyzing the FLASH
sequence in all right knees rather than any of the other sequences acquired
as part of the OAI protocol was that previously published reports on the rate
and sensitivity to change of cartilage morphology have been based on the
FLASH or similar sequences from other vendors.
All MR acquisitions were reviewed for artifacts, coverage and complete-
ness by the MR technologists and were immediately reacquired if needed.
Images were then sent for central archiving and preparation for release at
Synarc Inc. and the UCSF Coordinating Center. A small sample of the MR
images underwent visual quality assurance checks at Synarc and at
UCSF. The MR images were provided on an external hard drive by the
OAI Coordinating Center and were each quality controlled in detail and con-
verted to a proprietary format at the image analysis center (Chondrometrics
GmbH, Ainring, Germany). Segmentation of the FT cartilage plates wasperformed by seven technicians with formal training and at least 3 years of
experience in cartilage segmentation5. Images were read in pairs blinded
to the acquisition order. Segmentation included manual tracing of the tAB
and the cartilage joint surface area (AC) of the medial tibia (MT), the lateral
tibia (LT), the central (weight-bearing) medial femoral condyle (cMF) and the
central lateral femoral condyle (cLF)5,13. The weight-bearing region of the
femoral condyles was analyzed between the intercondylar notch and 60%
of the distance to the posterior end of the femoral condyles5,10,11. Quality
control of all segmentations was performed by a single expert (S.M.), review-
ing all segmented slices of every data set5. The segmentations were used to
compute the cartilage thickness over the entire subchondral bone area
(ThCtAB) and included denuded areas as 0 mm cartilage thickness5,13.
In MT and LT ﬁve subregions (central, internal, external, anterior, poste-
rior) were computed based on the tAB (Fig. 1), with the central subregion ini-
tially (default) occupying 20% of the total tAB3. The central tibial region was
deﬁned as a cylinder around the center of gravity of the tibial tAB, in which
the diameters were adapted to the individual shape of the bone interface
area3 (Fig. 1). Further computations were then performed with the central tib-
ial region occupying 10%, 30%, 40% or 50% of the tibial tAB3 (Fig. 2).
Since the weight-bearing femoral condyles are already limited in their an-
terior-posterior extension (by the femoral trochlea anteriorly, and the poste-
rior femoral condyle posteriorly), they were subdivided into central,
internal, and external strip-like regions of interest, each occupying 33.3%
of the tAB in the initial (default) approach (Fig. 1). Further computations
were then performed with the central femoral region occupying 25%, 50%,
66% and 75% of the femoral tAB3 (Fig. 2).
The mean cartilage thickness was computed for all subregions, and the
minimal cartilage thickness for the central subregions. Note that the minimal
thickness was not determined at a single point, but was the mean of 1% of
the smallest values in the central area3. The mean change from baseline
to follow up, the SD of change, the standardized response mean
(SRM¼mean change/SD of change), and the signiﬁcance of change (paired
t test, without correction for multiple testing) was then calculated for each
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Fig. 2. Image showing FT subregions of different sizes: (A) cMT
covering 10% of the tibial subchondral bone area (superior view).
(B) cMT covering 50% of the tibial subchondral bone area (superior
view). (C) ccMF covering 25% of the femoral subchondral bone
area (inferior view). (D) ccMF covering 75% of the femoral sub-
chondral bone area (inferior view).
293Osteoarthritis and Cartilage Vol. 17, No. 3cartilage plate, subregion and parameter. Note that the mean percent
change (MC%) was not obtained by calculating the mean of individual %
changes, but by relating the mean change (in mm) to the mean baseline
values in the subcohort. For total cartilage plates and for the central subre-
gions, changes were also reported for the medial (MFTC) and lateral
(LFTC) FT compartments, by using summed values from MT and weight-
bearing medial femoral condyle (cMF), and LT and weight-bearing lateral
femoral condyle (cLF), respectively11,12. Analysis of variance (ANOVA) of re-
peated measures was used to identify whether the change in mean cartilage
thickness (ThCtAB.Me) between baseline and 1 year follow up differed be-
tween the subregions of each cartilage plate, both in the total sample and
in the high risk subcohort. Post hoc tests were then used to identify between
which subregions signiﬁcant differences (in change) occurred; the signiﬁ-
cance level was set to 5% and P values were adjusted based on the Bonfer-
roni method. Additionally, a paired (2-sided) t test was then used to test
whether the percent changes in the central areas of MT/LT (20% tAB),
and cMF/cLF (33%tAB) were signiﬁcantly greater than those in the total car-
tilage plates, with a P value <0.05 considered statistically signiﬁcant. Ninety-
ﬁve percent conﬁdence intervals (CIs) were computed for each parameter,
also using the observed distribution of percent changes.ResultsMEDIAL FT COMPARTMENTIn the total weight-bearing femoral condyle (cMF), themean
cartilage thickness decreased by 4.1% (95% CI: 1.9%e6.4%)over the 12 month observation period in the high risk subco-
hort (KeL grade 2/3 and obesity; n¼ 54) and by 1.9%
(95%CI: 0.9%e2.9%) in the total subcohort (n¼ 156). ANOVA
of repeated measures identiﬁed signiﬁcant differences in the
change of mean cartilage thickness of cMF between baseline
and follow up (P< 0.001 for the total cohort and P< 0.01 for
the high risk subcohort). The thickness loss in the central sub-
region of cMF was signiﬁcantly greater (Bonferroni corrected
post hoc test) than that in the external and internal aspect of
cMF (Table I); this applied to both the total cohort (P< 0.01)
and to the high risk cohort (P< 0.05). When analyzing a cen-
tral subregion of 33% of the tAB in cMF (ccMF33), the reduc-
tion in mean cartilage thickness was signiﬁcantly greater
(P< 0.05; paired t test) than for the total plate (cMF) and
amounted to 5.8% (95%CI: 2.5%e9.1%) in the high risk cohort
and 2.8% (95%CI: 1.4%e4.2%) in the total cohort (Table I,
Fig. 3). The minimal thickness decreased by 9.2% (95%CI:
3.4%e15.1%) and 4.2% (95%CI: 1.5%e7.0%), respectively.
When varying the size of the central area (ccMF) the rate of
cartilage loss tended to be higher the smaller the region was
chosen (5.9% for 25% tAB vs 4.9% for a 75% tAB in the
high risk subcohort e Table I, Fig. 4).
The SRM for mean cartilage thickness of cMF was 0.49
in the high risk subcohort and 0.30 in the total subcohort.
When considering ccMF33, the SRM for the mean cartilage
thickness was similar (0.47 and 0.31), and that for min-
imal thickness was lower (0.42 and 0.24 e Table I). The
SRM in the external and internal aspect of cMF was lower
than for the entire cMF. The SRM varied little with the
size of central area (0.47 at 25% tAB to 0.50 at 75%
tAB in the high risk subcohort e Table I).
In the MT, the mean cartilage thickness decreased by
1.0% (95%CI: 0.1%e2.0%) in the high risk subcohort and
by 0.5% (95%CI: 0.01%e1.0%) in the total subcohort. No
signiﬁcant differences in the change of the mean cartilage
thickness between the subregions of MT was identiﬁed by
ANOVA (P¼ 0.08 for the total cohort and P¼ 0.12 for the
high risk subcohort), with the results in the subregions being
displayed in Table I. When considering a central area of
20% tAB in MT (central MT, cMT20), the reduction in
mean cartilage thickness was, however, greater (P¼ 0.01)
than for the total MT and amounted to 1.6% (95%CI:
0.1%e3.0%) and 0.9% (95%CI: 0.2%e1.5%), respectively
(Table I, Fig. 3). The minimal thickness decreased by
1.8%/1.5% (neither statistically signiﬁcant e Table I).
When varying the size of the central area (cMT) the rate
of cartilage loss tended to be greater the smaller the region
was chosen (2.1% for 10% tAB vs 1.3% for a 50% tAB in
the high risk subcohort e Table I, Fig. 4).
The SRM for mean cartilage thickness of MT was 0.24 in
the high risk subcohort and 0.16 in the total subcohort.
When considering cMT (20% tAB), the SRM for the mean car-
tilage thicknesswas somewhat higher (0.29 and0.20), and
that for minimal thickness lower (0.11 and 0.11 e Table I).
The SRM in the peripheral areas was similar or lower than for
the entire MT, and there was little variation with the size of
central area (0.33 at 10% tAB to 0.29 at 50% tAB).
Analysis of MFTC provided similar results to that of cMF,
with the mean and minimal cartilage thickness of the central
areas yielding a higher rate of change, but a similar SRM to
the total MFTC (Table I).LATERAL FT COMPARTMENTThere was no statistically signiﬁcant change in cLF, nei-
ther for the entire cartilage plate, nor for any of the subre-
gions (Table II). Also, no signiﬁcant differences in the
Table I
Total plate and regional cartilage changes in OAI progression subcohort over 1 year in the MFTC
Total cohort (n¼ 156) High risk cohort (n¼ 54)
MC% SRM P value MC% SRM P value
cMF.ThCtAB.Me 1.92 0.30 0.0002* 4.12 0.49 0.0007*
ccMF.ThCtAB.Me[33] 2.78 0.31 0.0001* 5.82 0.47 0.0010*
ecMF.ThCtAB.Me[33] 1.60 0.22 0.0078* 3.80 0.43 0.0025*
icMF.ThCtAB.Me[33] 1.37 0.25 0.0018* 2.80 0.42 0.0034*
ccMF.ThCtAB.Min[33] 4.22 0.24 0.0027* 9.22 0.42 0.0033*
ccMF.ThCtAB.Me[25] 2.87 0.32 0.0001* 5.92 0.47 0.0011*
ccMF.ThCtAB.Me[50] 2.61 0.32 0.0001* 5.55 0.49 0.0007*
ccMF.ThCtAB.Me[66] 2.44 0.32 0.0001* 5.14 0.50 0.0006*
ccMF.ThCtAB.Me[75] 2.29 0.32 0.0001* 4.89 0.50 0.0005*
MT.ThCtAB.Me 0.52 0.16 0.0427* 0.95 0.24 0.0890
cMT.ThCtAB.Me[20] 0.85 0.20 0.0151* 1.57 0.29 0.0356*
eMT.ThCtAB.Me[20] 0.76 0.13 0.1087 1.37 0.17 0.2255
iMT.ThCtAB.Me[20] 0.62 0.18 0.0301* 0.93 0.23 0.1021
aMT.ThCtAB.Me[20] 0.21 0.05 0.5715 0.17 0.03 0.8112
pMT.ThCtAB.Me[20] 0.22 0.06 0.4931 0.71 0.18 0.1929
cMT.ThCtAB.Min[20] 1.53 0.11 0.1658 1.81 0.11 0.4274
cMT.ThCtAB.Me[10] 1.13 0.23 0.0053* 2.06 0.33 0.0183*
cMT.ThCtAB.Me[30] 0.76 0.19 0.0183* 1.46 0.29 0.0383*
cMT.ThCtAB.Me[40] 0.75 0.20 0.0133* 1.42 0.30 0.0317*
cMT.ThCtAB.Me[50] 0.72 0.20 0.0124* 1.33 0.29 0.0379*
MFTC.ThCtAB.Me 1.23 0.31 0.0001* 2.53 0.47 0.0010*
cMFTC.ThCtAB.Me[20/33] 1.74 0.33 0.0001* 3.47 0.48 0.0008*
cMFTC.ThCtAB.Min 2.82 0.24 0.0027* 5.10 0.36 0.0116*
MC%¼mean change (in %), SRM (mean change/SD of change), ThCtAB.Me¼mean thickness of the cartilage over the entire subchondral
bone area, ThCtAB.Min¼minimal thickness of the cartilage over the tAB, ccMF¼ central cMF, ecMF¼ external cMF, icMF¼ internal cMF,
MT¼medial tibia, cMT¼ central MT, eMT¼ external MT, iMT¼ internal MT, aMT¼ anterior MT, pMT¼ posterior MT, [XX]¼% of the tAB
covered by the speciﬁc region of interest (values of MT and cMF added).
*Marked P values indicate a statistically signiﬁcant (P< 0.05) change in progression.
294 W. Wirth et al.: Regional cartilage loss in OAI progression subcohortchange of the mean cartilage thickness between the subre-
gions of cLF were identiﬁed by ANOVA (P¼ 0.75 for the to-
tal cohort and P¼ 0.91 for the high risk subcohort).
In the LT, themean cartilage thickness decreased by 1.1%
(95%CI: 0.4%e1.9%) in the high risk subcohort and by 0.7%
(95%CI: 0.2%e1.1%) in the total subcohort (Table II). AN-
OVA identiﬁed signiﬁcant differences in the change of
mean cartilage thickness of LT between baseline and follow
up (P< 0.05 for the total cohort and for the high risk subco-
hort, respectively). The change in central LT (cLT) was signif-
icantly greater (Bonferroni corrected post hoc test) than in
anterior LT (aLT) in the total cohort (P< 0.01) and in the
high risk subcohort (P< 0.05; Table II). When considering
a 20% central area (cLT20), the decrease in mean cartilage
thickness was signiﬁcantly (P< 0.01) greater than for the to-
tal LT and amounted to 1.6% (95%CI: 0.5%e2.7%) and 1.0%
(95%CI: 0.2%e1.6%), in the two groups. The minimal thick-
ness decreased by 1.3% and 0.8%, respectively (neither sta-
tistically signiﬁcant, Table II). When varying the size of the
central area (cLT), the rate of cartilage loss tended to be
greater for smaller regions of interest (1.7% for 10% tAB vs
1.3% for a 50% tAB in the high risk subcohort, Table II).
The SRM for mean cartilage thickness of LT was 0.39 in
the high risk subcohort and 0.23 in the total subcohort.
When considering cLT20, the SRM for the mean cartilage
thickness was similar (0.38 and 0.21), and that for min-
imal thickness lower (0.13 and 0.06 e Table II). The SRM
in the peripheral areas tended to be lower than for the entire
MT. The SRM varied little with the size of central area
(0.20 at 10% tAB to 0.22 at 50% tAB) for the entire
cohort, but the SRM tended to increase with larger centralareas of interest in the high risk cohort (0.34 at 10% tAB
to 0.40 at 50% tAB e Table II).
As cLF, analysis of the LFTC as a compartment did not
yield statistically signiﬁcant changes over the observation
period (Table II).Discussion
This is the ﬁrst study to present longitudinal observations
of cartilage change in medio-lateral subregions of the
weight-bearing femoral condyle, and for minimal cartilage
thickness in subregions of tibial and femoral cartilages.
Also, this is the ﬁrst study to examine subregional (speciﬁ-
cally central) cartilage thickness changes with 3 T MRI,
and the effect of the size of the central subregions on mea-
surements of the rate and sensitivity to change of FT carti-
lage loss in OA. These observation are important for two
reasons: (1) the ability to monitor cartilage change in differ-
ent subregions of the FT compartments and cartilage plates
allows one to more comprehensively describe cartilage loss
in OA and therefore better understand the disease and its
progression; (2) the ability to determine deﬁned subregions
with higher rates of change and in particular sensitivity to
change may permit a reduction in the required sample
size in clinical studies trying to demonstrate drug effects
on disease progression.
Our data show that the central subregions generally dis-
play higher rates of change than the total cartilage plates
(statistically signiﬁcant for MT, LT and cMF). The greatest
rates of change were observed for ‘‘minimal’’ rather than
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Fig. 4. Bar graphs showing the percent (%) annual change in mean
cartilage thickness (ThCtAB.Me) in total cartilage plates and in cen-
tral subregions of various sizes. (A) cMT 10e50%. (B) ccMF
25e75% The dark bar shows values for the total cartilage plate,
the white bar those for the standard (default) central subregions,
and the gray bars those for central subregions of other sizes (%
of the subchondral bone area).
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Fig. 3. Bar graph showing the percent (%) annual change in mean
cartilage thickness (ThCtAB.Me) in total cartilage plates (MT, cMF)
and in the standard (default) central subregions (cMT [20%], ccMF
[33%]) for the entire subcohort (all; n¼ 157) and for the high risk sub-
cohort with radiographicKeL grade2 and3 andobesity (HR;n¼ 54).
295Osteoarthritis and Cartilage Vol. 17, No. 3‘‘mean’’ cartilage thickness; the sensitivity to change (SRM)
of minimal cartilage thickness was, however, inferior to that
of the mean thickness, due to a larger inter-subject variabil-
ity. The sensitivity to change for mean cartilage thickness in
the central subregion of the MT was higher than that for the
entire cartilage plate, relatively independent of the choice of
size of the region (10e50% tAB), whereas in cMF and LT
the SRM was similar for central subregions and the entire
cartilage plate. A limitation of the study is that the biome-
chanical axis of the leg (neutral, valgus or varus malalign-
ment) was not measured, and future work should
therefore address whether the observations made here
also apply to subcohorts with different types of knee
alignment.
In a previous study, we showed that the algorithm applied
here is able to reliably identify regions of interest of a deﬁned
proportion of the tAB in FT cartilage plates, and that a test-
retest precision (RMS CV%) of 1.5% (external MT,
eMT)e3.5% (external cMF, ecMF) can be obtained in the
medial FT, and of 1.9% (cLT) to 4.7% (posterior LT, pLT)
in the LFTC3. The test-retest precision error for minimal
thickness (central regions) ranged from 5.0% in cLT to
10.1% in ccLF3. Also, we have reported that total plate car-
tilage loss tended to be higher in those with a BMI> 30 than
in those with lower BMI, and higher in those with KeL grade
2 and 3 than in those with other KeL grades in this cohort5;
however, only trends were observed and non of these or
other potential risk factors (age, sex, symptoms) were found
to be signiﬁcantly associated with FT cartilage loss.
In a recent study, Pelletier et al.2 investigated a subset of
110 patients from a large clinical trial who suffered from
symptomatic and radiographic (deﬁnite osteophyte) knee
OA, a narrower medial than lateral joint space, and a medial
joint space width between 2 and 4 mm on semiﬂexed radio-
graphs. The tibial cartilage was divided either into a concen-
tric or a transverse (medial to lateral) central region. Theauthors2 also reported that the highest rate of change
(over 2 years) occurred in the central areas (13% in con-
centric and 15% in transverse cMT, as opposed to 9.3%
in the total MT). The SRM was, however, similar for regional
(1.19 for concentric and 1.25 for transverse cMT) and for
total plate analysis of MT (1.24). The medial femoral con-
dyle was divided into an anterior, central (cMF) and poste-
rior (pMF) subregion (rate of change¼12.4, 12.0 and
4.4% and SRM¼1.03, 1.04, and 0.56, respectively),
but was not divided into medio-lateral subregions, as in the
current study. The data were presented as cartilage volume
change in these subregions, but not in terms of mean and
minimal cartilage thickness.
Despite the use of 3 T, the rate of change and SRMs ob-
served in the total and in the high risk subcohort of the pres-
ent study were lower than those reported by Pelletier et al.2,
even when accounting for the 2 years observation period in
their study. Similar to these authors, however, we ﬁnd that
the central subregions display a higher rate of change
than the total cartilage plates, whereas the SRMs are simi-
lar for central subregions and the total plate. The only
Table II
Total plate and regional cartilage changes in OAI progression subcohort over 1 year in the LFTC
Total cohort (n¼ 156) High risk cohort (n¼ 54)
MC% SRM P value MC% SRM P value
cLF.ThCtAB.Me 0.09 0.02 0.7682 0.14 0.03 0.8258
ccLF.ThCtAB.Me[33] 0.05 0.01 0.9061 0.27 0.05 0.7287
ecLF.ThCtAB.Me[33] 0.02 0.00 0.9617 0.14 0.02 0.8576
icLF.ThCtAB.Me[33] 0.28 0.06 0.4573 0.01 0.00 0.9948
ccLF.ThCtAB.Min[33] 0.19 0.01 0.8605 2.48 0.20 0.1524
ccLF.ThCtAB.Me[25] 0.06 0.01 0.8837 0.36 0.06 0.6670
ccLF.ThCtAB.Me[50] 0.07 0.02 0.8380 0.30 0.06 0.6765
ccLF.ThCtAB.Me[66] 0.08 0.02 0.8128 0.26 0.05 0.7160
ccLF.ThCtAB.Me[75] 0.07 0.02 0.8467 0.18 0.03 0.7995
LT.ThCtAB.Me 0.68 0.23 0.0046* 1.13 0.39 0.0064*
cLT.ThCtAB.Me[20] 0.94 0.21 0.0084* 1.58 0.38 0.0070*
eLT.ThCtAB.Me[20] 0.87 0.21 0.0084* 1.04 0.23 0.0972
iLT.ThCtAB.Me[20] 0.84 0.20 0.0146* 1.20 0.25 0.0742
aLT.ThCtAB.Me[20] 0.18 0.04 0.6601 0.27 0.06 0.6746
pLT.ThCtAB.Me[20] 0.88 0.16 0.0510 1.90 0.34 0.0145*
cLT.ThCtAB.Min[20] 0.82 0.06 0.4824 1.31 0.13 0.3521
cLT.ThCtAB.Me[10] 1.02 0.20 0.0123* 1.74 0.34 0.0144*
cLT.ThCtAB.Me[30] 0.90 0.23 0.0046* 1.45 0.39 0.0055*
cLT.ThCtAB.Me[40] 0.80 0.22 0.0071* 1.37 0.40 0.0049*
cLT.ThCtAB.Me[50] 0.76 0.22 0.0066* 1.31 0.40 0.0052*
LFTC.ThCtAB.Me 0.30 0.11 0.1653 0.49 0.17 0.2231
cLFTC.ThCtAB.Me[20/33] 0.51 0.14 0.0723 0.75 0.20 0.1514
cLFTC.ThCtAB.Min 0.38 0.04 0.6494 0.39 0.04 0.7482
MC%¼mean change (in %), SRM (mean change/SD of change); cLF, ThCtAB.Me¼mean thickness of the cartilage over the entire sub-
chondral bone area, ThCtAB.Min¼minimal thickness of the cartilage over the tAB, ccLF¼ central cLF, ecLF¼ external cLF, icLF¼ internal
cLF, LT¼ lateral tibia, cLT¼ central LT, eLT¼ external LT, iLT¼ internal LT, aLT¼ anterior LT, pLT¼ posterior LT, [XX]¼% of the tAB cov-
ered by the speciﬁc region of interest (values of LT and cLF added).
*Marked P values indicate a statistically signiﬁcant (P< 0.05) change in progression.
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for cMT was higher than for the total plate. No signiﬁcant
change was found in the high risk subcohort for the entire
MT, whereas a signiﬁcant loss was observed in cMT.
The minimal central cartilage thickness generally dis-
played greater rates of change than the mean thickness
of the central subregions or total plates, but lower SRMs.
In a diseased joint, the minimal cartilage thickness in central
areas is likely located at the site of a lesion, where cartilage
loss may occur faster than in other parts of the joint. There-
fore, it is plausible that the rate of change for minimal carti-
lage thickness change was higher than that for mean
cartilage thickness. However, the inter-subject variability in
the change in minimal thickness was also higher, likely be-
cause of larger changes in subjects without full thickness
cartilage loss, or the absence of any loss in minimal thick-
ness in participants with a central denuded area at baseline.
In the high risk subcohort, 6 (of 54) participants had already
0 mm minimal cartilage thickness in cMT at baseline, and
13 (of 54) in ccMF. Because no loss of minimal cartilage
thickness can be measured in these subjects, the SD of
the change is larger compared to the SD of change in
mean cartilage thickness, with the mean thickness of cMT
and ccMF having been greater than zero in all participants.
The other potential explanation is the larger precision errors
involved in measurement of the minimal cartilage thick-
ness3, given that measurements are averaged over
a much smaller area and therefore much more prone to in-
consistencies in local segmentation and are more sensitive
to partial volume averaging. Note that the average minimal
cartilage thickness was 1.36 mm in cMT and 1.09 mm incMF, so that the size of one pixel (0.31 mm) amounts to
23% and 28% of that value, respectively.
Similar considerations apply to the choice in size of the
subregions. Despite the fact that the higher rate of change
was generally observed with a smaller central region of in-
terest, this did not translate into a higher SRM, because of
the proportional increase in the SD of the change in the
smaller area. Again, a potential explanation may be the
larger inter-subject variability of cartilage thickness changes
measured in smaller areas compared to larger ones, or
greater test-retest precision error in smaller areas. This
was previously observed in the medial but not in the LFTC3.
In conclusion, this study shows that the rate of cartilage
loss is greater in the central subregions compared to the total
cartilage plates. Minimal (central) cartilage thickness dis-
played a greater rate of change than the mean thickness,
but the SRM was less, due to greater variability of the
changes. Smaller central subregions generally displayed
higher rates of change than larger central subregions, but
this did not translate into a higher SRM for the same reason.
The sensitivity to change for the central subregions was
greater than in the total cartilage plate in theMT andwas sim-
ilar to the entire cartilage plate in the medial femur and LT.Conﬂict of interest
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